The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 06, 2021

Filed:

Dec. 12, 2016
Applicant:

Vanderbilt University, Nashville, TN (US);

Inventors:

Justin M. Balko, Brentwood, TN (US);

Douglas B. Johnson, Nashville, TN (US);

Violeta Sanchez de Delgado, Nashville, TN (US);

Melinda Sanders, Nashville, TN (US);

Assignee:

Vanderbilt University, Nashville, TN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); G01N 33/574 (2006.01); A61K 31/416 (2006.01); C07K 16/28 (2006.01); A61K 38/45 (2006.01); A61K 31/166 (2006.01); A61K 31/44 (2006.01); A61K 31/4523 (2006.01); A61K 31/519 (2006.01); A61K 31/4412 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5743 (2013.01); A61K 31/166 (2013.01); A61K 31/416 (2013.01); A61K 31/44 (2013.01); A61K 31/4412 (2013.01); A61K 31/4523 (2013.01); A61K 31/519 (2013.01); A61K 38/45 (2013.01); C07K 16/2818 (2013.01); C07K 16/2833 (2013.01); G01N 33/56977 (2013.01); G01N 33/57407 (2013.01); A61K 2039/505 (2013.01); G01N 2333/70539 (2013.01);
Abstract

A method of detecting cell membrane expression of an MHC molecule in a subject, a method of treating cancer in a subject with an immunotherapeutic agent, and an MHC complex are provided. The method of detecting cell membrane expression of an MHC molecule includes obtaining a tumor cell sample from a subject, and detecting cell membrane expression of the MHC molecule by contacting the tumor cell sample with an antibody targeting the MHC molecule and detecting binding between the MHC molecule and the antibody. The method of treating cancer in a subject with an immunotherapeutic agent includes detecting cell membrane expression of an MHC molecule in the subject and administering a therapeutically effective amount of the immunotherapeutic agent if the level of cell membrane expression of the MHC molecule exceeds a predetermined standard. The complex includes a tumor cell in complex with an antibody or an antigen-binding portion thereof.


Find Patent Forward Citations

Loading…